366 related articles for article (PubMed ID: 26952679)
1. Predicting women's intentions for contralateral prophylactic mastectomy: An application of an extended theory of planned behaviour.
Richards I; Tesson S; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
Eur J Oncol Nurs; 2016 Apr; 21():57-65. PubMed ID: 26952679
[TBL] [Abstract][Full Text] [Related]
2. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
[TBL] [Abstract][Full Text] [Related]
3. Women's preferences for contralateral prophylactic mastectomy: An investigation using protection motivation theory.
Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
Patient Educ Couns; 2016 May; 99(5):814-22. PubMed ID: 27529090
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing the surgery intentions and choices of women with early breast cancer: the predictive utility of an extended theory of planned behaviour.
Sivell S; Elwyn G; Edwards A; Manstead AS;
BMC Med Inform Decis Mak; 2013 Aug; 13():92. PubMed ID: 23962230
[TBL] [Abstract][Full Text] [Related]
5. Women's decision-making roles regarding contralateral prophylactic mastectomy.
Nekhlyudov L; Bower M; Herrinton LJ; Altschuler A; Greene SM; Rolnick S; Elmore JG; Harris EL; Liu A; Emmons KM; Fletcher SW; Geiger AM
J Natl Cancer Inst Monogr; 2005; (35):55-60. PubMed ID: 16287886
[TBL] [Abstract][Full Text] [Related]
6. 'Taking control of cancer': understanding women's choice for mastectomy.
Covelli AM; Baxter NN; Fitch MI; McCready DR; Wright FC
Ann Surg Oncol; 2015 Feb; 22(2):383-91. PubMed ID: 25190120
[TBL] [Abstract][Full Text] [Related]
7. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
Tollow P; Williams VS; Harcourt D; Paraskeva N
Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
[TBL] [Abstract][Full Text] [Related]
8. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
[TBL] [Abstract][Full Text] [Related]
9. Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy.
Rendle KA; Halley MC; May SG; Frosch DL
Qual Health Res; 2015 Sep; 25(9):1251-9. PubMed ID: 25371380
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
[TBL] [Abstract][Full Text] [Related]
11. Issues of regret in women with contralateral prophylactic mastectomies.
Montgomery LL; Tran KN; Heelan MC; Van Zee KJ; Massie MJ; Payne DK; Borgen PI
Ann Surg Oncol; 1999 Sep; 6(6):546-52. PubMed ID: 10493622
[TBL] [Abstract][Full Text] [Related]
12. Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer.
Soran A; Ibrahim A; Kanbour M; McGuire K; Balci FL; Polat AK; Thomas C; Bonaventura M; Ahrendt G; Johnson R
Am J Clin Oncol; 2015 Apr; 38(2):179-83. PubMed ID: 23648435
[TBL] [Abstract][Full Text] [Related]
13. B-Sure: a randomized pilot trial of an interactive web-based decision support aid versus usual care in average-risk breast cancer patients considering contralateral prophylactic mastectomy.
Manne SL; Smith BL; Frederick S; Mitarotondo A; Kashy DA; Kirstein LJ
Transl Behav Med; 2020 May; 10(2):355-363. PubMed ID: 30608607
[TBL] [Abstract][Full Text] [Related]
14. Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
Parker PA; Peterson SK; Bedrosian I; Crosby MA; Shen Y; Black DM; Babiera G; Kuerer HM; Ying J; Dong W; Cantor SB; Brewster AM
Ann Surg; 2016 Jan; 263(1):178-83. PubMed ID: 25822675
[TBL] [Abstract][Full Text] [Related]
15. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
16. Decisional conflict among breast cancer patients considering contralateral prophylactic mastectomy.
Manne S; Smith B; Mitarotondo A; Frederick S; Toppmeyer D; Kirstein L
Patient Educ Couns; 2019 May; 102(5):902-908. PubMed ID: 30553577
[TBL] [Abstract][Full Text] [Related]
17. Tools for Contralateral Prophylactic Mastectomy Decision Making.
Gail MH; Jatoi I
J Clin Oncol; 2022 Nov; 40(31):3653-3659. PubMed ID: 35759730
[TBL] [Abstract][Full Text] [Related]
18. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
[TBL] [Abstract][Full Text] [Related]
19. Contralateral prophylactic mastectomy: A qualitative approach to exploring the decision making process.
Greener JR; Bass SB; Lepore SJ
J Psychosoc Oncol; 2018; 36(2):145-158. PubMed ID: 29064771
[TBL] [Abstract][Full Text] [Related]
20. Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer.
Metcalfe KA; Retrouvey H; Kerrebijn I; Butler K; O'Neill AC; Cil T; Zhong T; Hofer SOP; McCready DR
Cancer; 2019 Nov; 125(22):3966-3973. PubMed ID: 31435939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
